Rigorous Compliance and Thorough Corruption Prevention

Compliance is the heart of corporate social responsibility (CSR). As a corporate Group that provides products and services related to health and life to people around the world, the Eiken Group has a special duty to adhere rigorously to the law in its activities and maintain the highest standards of corporate ethics. In order to foster and maintain a corporate culture with high ethical standards, we have established the Compliance Policy, Anti-Bribery Policy, Supplier Sustainability Policy, Human Rights Policy, Risk Management Policy, and Information Security Policy. Based on these policies, we have established the Eiken Group Global Code of Conduct, and every Eiken Group employee comply with it and act responsibly in a manner that is trusted by medical professionals and the general public.
Based on the compliance policy, Eiken Chemical has drafted the Eiken Group Compliance Regulations. To provide a mechanism for promoting compliance, the Group has established a Risk Management and Compliance Committee. This body promotes corporate ethics and compliance and continuously assesses and manages risk. In addition, Eiken Chemical has created contact points for whistleblower reports, where employees can report irregularities and consult about compliance issues. External reports and requests for consultation are received through the Company’s “Contact Us” page.

➡Compliance Policy
➡Anti-Bribery Policy
➡Supplier Sustainability Policy
➡Risk Management Policy
➡Information Security Policy
➡Human Rights Policy

Due to our involvement with life and the provision of products and services for protecting the health of people all over the world, the Eiken Group strives to achieve fair and appropriate management and maintain harmony with societal demands through the implementation of compliance activities.

The Eiken Group has established the "Eiken Group Global Code of Conduct" and the "Eiken Group Compliance Regulations" as guidelines for behavior based on social norms. As part of its compliance promotion system, the Group has set up the "Risk Management and Compliance Committee," chaired by the Director,Senior Managing Executive Officer, General , Business Management Division and comprised of all Executive Officers, with executive officers as members. Additionally, the "Risk Management and Compliance Promotion Committee," with managers at each business site as members, has been established as a subcommittee. Through the activities of these committees, the company promotes corporate ethics and legal compliance in a comprehensive and systematic manner, while continuously monitoring legality and efficiency through audits by the internal audit department and joint audit meetings led by the Audit Committee.
Furthermore, the company posts the "Eiken Group Global Code of Conduct," "Compliance Policy," "Anti-Bribery Policy," and "Human Rights Policy" on the internal intranet, making them available for constant reference by employees. In addition, through regular training under the compliance program, the company works to raise awareness of these policies, the prohibition of corrupt practices, and the prevention of human rights violations.

Eiken Chemical has established internal and external whistleblowing hotlines and operates them in accordance with the whistleblowing regulations.. The whistleblowing hotline also allows anonymous consultations and reports, and employees who learn of the contents of the report and consultation are obligated to maintain confidentiality to protect the consulter from being disadvantaged.

The subject of the report is corrupt acts such as bribery, embezzlement, breach of trust, bid-rigging, other violations of laws and regulations, misconduct such as conflicts of interest, harassment, information leakage, and other violations of the Company's regulations, and suspected violations of compliance.

With regard to the whistleblowing system, we disseminate compliance cards to all employees through the distribution of compliance cards, posting on the company intranet, and training, and are working to quickly recognize and take measures against and correct compliance violations and suspicions. The Audit Committee monitors the operation of the whistleblowing system.

Under the our management philosophy of "Protecting people's health through health care," we promote research and development of many clinical diagnostics and devices. Clinical research is reviewed and approved by our research ethics review committee from an ethical and scientific perspective.

Eiken Chemical is resolute in its attitude, taking a firm stand against antisocial forces and organizations. Our fundamental beliefs on this matter are defined in the “Eiken Group Global Code of Conduct,” and our directors, executive officers, and all employees maintain thorough compliance with this code. In addition, we have established a division for handling issues related to antisocial forces and organizations, maintain strong cooperation with outside experts such as police and lawyers, and carry out appropriate organizational handling measures.

Based on the management philosophy that the Eiken Group “protects the health of the public through health care services,” the Eiken Group has established the “Eiken Group Global Code of Conduct," which indicates the actions that all of executives, employees and others should take to contribute to society by providing products and services that protect the health and life of people around the world. In the "Eiken Group Global Code of Conduct," we stipulate that all employees and others working in the Eiken Group conduct themselves honestly and responsibly based on the correct ethics.

In Japan and in all countries and regions where we operate business, we have established this policy as a guideline to further promote business activities based on the Eiken Group Code of Conduct and to fulfill the social responsibilities of the Eiken Group.

All employees and others of the Eiken Group comply with the anti-bribery laws and regulations of all countries and regions applicable to the Eiken Group.

No employee and others of the Eiken Group, both at home and abroad, engage in any of the following acts. Furthermore, we do not and will not engage in or tolerate the following acts through third parties such as consultants, agents, or distributors who have business relationships with the Eiken Group.

The Eiken Group records all transactions in its accounting books in a timely and accurate manner in accordance with internal regulations, and properly keeps relevant materials.

The Eiken Group provides all employees and others with appropriate anti-bribery education and training.

The Eiken Group establishes and maintains an anti-bribery management system to ensure that this policy is properly complied with by all employees and others of the Eiken Group. Furthermore, we regularly assess bribery risks in the Eiken Group and continuously improve our anti-bribery management system.

The Eiken Group also asks for the understanding and cooperation to this policy of third parties such as consultants, agents and distributors in business relationships.

If the Eiken Group discovers any conduct that violates or is likely to violate this policy, it will conduct a rigorous investigation and take strict measures in accordance with internal regulations.

(1) “Employees and others" refers to all people who work at the Eiken Group, including executives, full-time employees, seconded employees, dispatched employees, part-time employees, and others

(2) The term "public officials, and the like" refers to domestic public officials, foreign and other public officials, persons engaged in the official business of international organizations, and officers and employees, and others of companies that are substantially controlled by the government or local public organizations in Japan or abroad.

(3) "Facilitation payment" refers to a small payment of money paid to a public official, and the like to facilitate or expedite a process of routine administrative services.

Formulated: April 1, 2022
President and CEO
Eiken Chemical Co., Ltd.

The Eiken Group’s Legal Division strictly complies with this policy and provides appropriate training on prevention of bribery. The Group also regularly assesses corruption risk within itself and continuously improves its systems for management of bribery prevention.

The Eiken Group asks all third parties with whom it does business, including consultants, agents and sales outlets, to understand and cooperate with this policy.

For more information on human rights due diligence, please see the "Respecting for Human Rights and Diversity" page.

The Eiken Group Global Code of Conduct establishes action guidelines for promotion activities.
This guideline refers to the Guidelines for the Promotion of In Vitro Diagnostics, the Guidelines for Corporate Activities of In Vitro Diagnostics, Guidelines for Clinical Research on In Vitro Diagnostics, Management Standards for Trial In-Vitro Diagnostic Reagents, Guidelines for the Exhibition of Unapproved Medical Devices, and Regulations of Each Country and Region.
As part of our management system, we have established a department within the company to supervise sales information provision activities, and we monitor whether appropriate promotional activities are being carried out, such as reviewing promotional materials (product brochures, websites, etc.). In addition, we strive to maintain and improve the high ethical sense of each and every employee by conducting education and training on the Pharmaceuticals and Medical Devices Act and the GVP Ministerial Ordinance for all employees, as well as education and training on the Antimonopoly Act, the Act on Unjustifiable Premiums and Misleading Representations, the National Public Service Ethics Act and the Fair Competition Code for employees on relevant division (Sales Division, R&D Division, etc.).

■ We will be fully aware of our social mission as a part of medical care, comply with relevant laws and regulations, and act sensibly.
■ We will continue to provide information on the quality, efficacy, and safety necessary for the use of our products in a reliable and appropriate manner based on data with a clear scientific basis.
■ We will accurately and promptly collect and evaluate information on in-vitro diagnostics after manufacturing and marketing and communicate it to medical professionals.
■ We will comply with relevant laws, regulations, and self-regulations when creating, using, and posting promotional printed materials and advertisements, and will be accurate, fair, and objective.
■ When we provide goods, money, or services to medical institutions, we will not provide them beyond the scope that is deemed appropriate in light of normal business practices.
■ We, Diagnostics Medical information Representatives, will continue to provide education and training to improve the level of clinical diagnostics.

The Risk Management and Compliance Committee, which is comprised of all executive officers, has established and implemented an education and training plan to raise compliance awareness.
In terms of education and training, we regularly provide education and training to all employees on the themes of human rights protection, harassment prevention, bribery prevention, insider trading, and regulatory compliance, based on the Eiken Group Global Code of Conduct.
In terms of inspections and improvements, in addition to implementing legal measures as needed, we also conduct disaster countermeasures and BCP drills every year.

In terms of monitoring, we conduct comprehension tests and fact-finding questionnaires at each training session, and conduct employee satisfaction surveys and compliance awareness surveys for all employees every year to grasp, analyze, and improve the current situation.